Consequently, we propose that PI3K inhibition exerts its effect, at least in part, by suppressing the upstream recruitment of MDSCs, which are critical for upregulating the miR-155-5p/SIRT1 pathway in tumor cells. Here, SIRT1 is linked to neoplasm.